Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Feinstein

Showing results (71-80 of 433) with videos related to

Pageof 44
Sort By:
Clinical Pharmacology and Therapeutics|September 1, 1973
Clinical biostatistics. 23. The role of randomization in sampling, testing, allocation, and credulous idolatry. 2A R Feinstein
Medical Care|May 1, 1992
Benefits and obstacles for development of health status assessment measures in clinical settingsA R Feinstein
Perspectives in Biology and Medicine|January 1, 1987
The intellectual crisis in clinical science: medaled models and muddled mettleA R Feinstein
Journal of Clinical Epidemiology|January 1, 1990
The inadequacy of binary models for the clinical reality of three-zone diagnostic decisionsA R Feinstein
Journal of Chronic Diseases|January 1, 1987
X and iprP: an improved summary for scientific communicationA R Feinstein
Journal of Clinical Epidemiology|January 1, 1988
Classification of epidemiologic researchA R Feinstein
Journal of Chronic Diseases|January 1, 1985
The case-control study: valid selection of subjectsA R Feinstein
Hypertension (Dallas, Tex. : 1979)|May 1, 1985
Tempest in a p-pot?A R Feinstein
Clinical Pharmacology and Therapeutics|January 1, 1977
Clinical biostatistics. XXXVIII. Computer malpracticeA R Feinstein
JAMA|January 17, 1986
Tourniquet test for capillary fragility in diabetesA R Feinstein
Pageof 44

Showing results (71-80 of 433) with videos related to

Sort By:
Pageof 44
Clinical Pharmacology and Therapeutics|September 1, 1973
Clinical biostatistics. 23. The role of randomization in sampling, testing, allocation, and credulous idolatry. 2A R Feinstein
Medical Care|May 1, 1992
Benefits and obstacles for development of health status assessment measures in clinical settingsA R Feinstein
Perspectives in Biology and Medicine|January 1, 1987
The intellectual crisis in clinical science: medaled models and muddled mettleA R Feinstein
Journal of Clinical Epidemiology|January 1, 1990
The inadequacy of binary models for the clinical reality of three-zone diagnostic decisionsA R Feinstein
Journal of Chronic Diseases|January 1, 1987
X and iprP: an improved summary for scientific communicationA R Feinstein
Journal of Clinical Epidemiology|January 1, 1988
Classification of epidemiologic researchA R Feinstein
Journal of Chronic Diseases|January 1, 1985
The case-control study: valid selection of subjectsA R Feinstein
Hypertension (Dallas, Tex. : 1979)|May 1, 1985
Tempest in a p-pot?A R Feinstein
Clinical Pharmacology and Therapeutics|January 1, 1977
Clinical biostatistics. XXXVIII. Computer malpracticeA R Feinstein
JAMA|January 17, 1986
Tourniquet test for capillary fragility in diabetesA R Feinstein
Pageof 44